|
|
cell adhesion
|
GO:0007155 |
329 |
0.649
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.628
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.578
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.576
|
Mouse |
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.545
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.539
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.492
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.469
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.466
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.443
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.442
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.435
|
Mouse |
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.421
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.405
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.403
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.395
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.390
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.367
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.365
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.344
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.338
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.334
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.319
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.319
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.316
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.302
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.298
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.288
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.284
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.282
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.273
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.257
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.255
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.253
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.252
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.251
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.251
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.243
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.242
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.241
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.241
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.239
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.233
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.233
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.232
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.231
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.231
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.224
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.222
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.220
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.218
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.218
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.218
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.216
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.215
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.213
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.209
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.207
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.205
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.204
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.203
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.200
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.197
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.197
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.196
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.195
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.195
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.194
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.194
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.191
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.190
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.188
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.188
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.187
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.185
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.185
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.184
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.183
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.180
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.179
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.178
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.178
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.178
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.176
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.176
|
|
|
|
regulation of catenin import into nucleus
|
GO:0035412 |
5 |
0.174
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.174
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.173
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.172
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.167
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.165
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.165
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.164
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.163
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.163
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.160
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.160
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.157
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.157
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.155
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.155
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.152
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.151
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.151
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.150
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.148
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.147
|
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.145
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.143
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.143
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.142
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.142
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.141
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.139
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.136
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.136
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.136
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.136
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.135
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.132
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.131
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.130
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.128
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.128
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.126
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.124
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.123
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.123
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.123
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.122
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.120
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.119
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.119
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.119
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.119
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.119
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.116
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.114
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.114
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.114
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.113
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.112
|
Mouse |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.112
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.111
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.110
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.110
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.110
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.109
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.109
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.108
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.107
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.107
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.106
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.106
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.105
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.104
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.104
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.103
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.103
|
Mouse |
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.102
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.102
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.102
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.102
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.101
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.101
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.100
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.100
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.100
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.097
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.097
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.096
|
Mouse |
|
|
epidermis development
|
GO:0008544 |
187 |
0.095
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.094
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.094
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.094
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.094
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.093
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.092
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.092
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.091
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.089
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.089
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.088
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.088
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.088
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.088
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.087
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.086
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.086
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.086
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.086
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.084
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.084
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.084
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.082
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.082
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.082
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.082
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.082
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.080
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.080
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.079
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.079
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.078
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.078
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.078
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.078
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.077
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.077
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.077
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.077
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.076
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.076
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.076
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.076
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.075
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.075
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.074
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.074
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.074
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.073
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.072
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.072
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.071
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.071
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.070
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.069
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.069
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.069
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.068
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.067
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.067
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.066
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.066
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.066
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.065
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.065
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.065
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.065
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.065
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.064
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.064
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.063
|
|
|
|
regulation of osteoblast proliferation
|
GO:0033688 |
15 |
0.063
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.063
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.062
|
|
|
|
sensory neuron axon guidance
|
GO:0097374 |
3 |
0.062
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.062
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.062
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.062
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.061
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.061
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.061
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.061
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.061
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.061
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.060
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.060
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.060
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.059
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.059
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.059
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.059
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.059
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.059
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.058
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.058
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.058
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.058
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.057
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.057
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.057
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.057
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.057
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.057
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.057
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.057
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.057
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.057
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.057
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.056
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.056
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.056
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.056
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.056
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.056
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.056
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.056
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.055
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.055
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.055
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.055
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.055
|
Mouse |
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.055
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.055
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.055
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.055
|
|
|
|
negative regulation of hepatocyte differentiation
|
GO:0070367 |
1 |
0.055
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.055
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.055
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.054
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.054
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.054
|
Mouse |
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.054
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.054
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.054
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.054
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.054
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.054
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.053
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.053
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.053
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.053
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.053
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.053
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.053
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.052
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.052
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.052
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.052
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.052
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.051
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.051
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.051
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.050
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.050
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.050
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.050
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.050
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.049
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.049
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.049
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.048
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.048
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.048
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.047
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.046
|
Mouse |
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.046
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.046
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.046
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.046
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by extracellular matrix epithelial cell signaling
|
GO:0060668 |
1 |
0.046
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.046
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.046
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.045
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.045
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.045
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.045
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.045
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.045
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.045
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.044
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.044
|
|
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.044
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.044
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.044
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.043
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.043
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.043
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.043
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.043
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.043
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.042
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.042
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.042
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.042
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.042
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.042
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.042
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.042
|
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.041
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.041
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.041
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.041
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.041
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.041
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.040
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.040
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.040
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.040
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.039
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.039
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.039
|
|
|
|
negative regulation of mitotic cell cycle embryonic
|
GO:0045976 |
2 |
0.039
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.039
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.039
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.039
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.039
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.039
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.038
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.038
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.038
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.038
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.038
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.038
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.038
|
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.038
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.038
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.038
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.038
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.038
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.037
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.037
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.037
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.037
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.036
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.036
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.036
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.036
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.036
|
Mouse |
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.036
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.036
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.036
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.035
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.035
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.035
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.035
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.035
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.035
|
|
|
|
layer formation in cerebral cortex
|
GO:0021819 |
13 |
0.034
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.034
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.034
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.034
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.034
|
|
|
|
cerebellum vasculature development
|
GO:0061300 |
1 |
0.034
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.034
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.034
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.034
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.034
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.034
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.034
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.034
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.033
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.033
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.033
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.033
|
|
|
|
epiboly
|
GO:0090504 |
8 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.033
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.033
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.033
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.033
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.032
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.032
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.032
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.032
|
Mouse |
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.032
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.032
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.032
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.032
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.032
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.032
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.031
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.031
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.031
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.031
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.031
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.031
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.031
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.031
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.031
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.031
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.031
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.030
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.030
|
Mouse |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.030
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.030
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.030
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.030
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.030
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.030
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.030
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.030
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.029
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.029
|
|
|
|
regulation of endothelial cell chemotaxis
|
GO:2001026 |
1 |
0.029
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.029
|
|
